Notice of NCI's Participation in RFA-HG-23-002, Broadening Opportunities for Computational Genomics and Data Science Education (UE5 – Clinical Trial Not Allowed)
Notice Number:
NOT-CA-24-006

Key Dates

Release Date:

November 3, 2023

Related Announcements

  • August 29, 2023 - Broadening Opportunities for Computational Genomics and Data Science Education (UE5 – Clinical Trial Not Allowed). see NOFO RFA-HG-23-002

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this notice of participation is to inform the extramural community that NCI is participating in RFA-HG-23-002, Broadening Opportunities for Computational Genomics and Data Science Education (UE5 – Clinical Trial Not Allowed).

The following changes in RFA-HG-23-002 reflect NCI's participation (in bold italics):

Part 1. Overview Information,

Components of Participating Organizations

National Human Genome Research Institute (NHGRI) (https://www.genome.gov/)

National Cancer Institute (NCI)

Assistance Listing Number(s)

93.172; 93.398
 

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

The NIH Research Education Program (UE5) supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers.

The overarching goal of this UE5 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in computational genomics and data science research.

This NOFO will support educational activities with a primary focus on:

  • Curriculum or Methods Development

Specifically, this NOFO will support the development of undergraduate and master’s degree-level classroom content, and hands-on as well as online exercises related to computational genomics, data science, cloud computing, or a combination of these topics, tailored towards students attending institutions with a mission to serve historically underrepresented populations in biomedical research as described below in Section III.

The National Cancer Institute encourages applications focused on educational activities that are related to computational cancer genomics, cancer data science, cloud computing for cancer focused activities, or a combination of these topics, tailored towards students attending institutions with a mission to serve historically underrepresented populations in biomedical research as described below in Section III. 

 

Part 2. Section VII. Agency Contacts 

Scientific/Research Contact(s)

Shurjo K. Sen, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-827-7028
Email: sensh@mail.nih.gov 
 

Nastaran Zahir, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6333
Email: nas.zahir@nih.gov

Peer Review Contact(s)
Rudy Pozzatti, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-402-8739
Email: rudy.pozzatti@nih.gov 
 

Financial/Grants Management Contact(s)
 Donna Morris
National Human Genome Research Institute (NHGRI)
Telephone: 301-827-2745
Email: donna.morris@nih.gov (mailto:donna.morris@nih.gov)

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: crystal.wolfrey@nih.gov

All other aspects of RFA-HG-23-002 remain unchanged.

Inquiries

Please direct all inquiries to:

Nastaran Zahir, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6333
Email: nas.zahir@nih.gov